Praxis Precision Medicines Inc (NASDAQ: PRAX) kicked off on Monday, up 13.25% from the previous trading day, before settling in for the closing price of $268.95. Over the past 52 weeks, PRAX has traded in a range of $26.70-$286.50.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 8.54%. While this was happening, its average annual earnings per share was recorded -28.03%. With a float of $23.15 million, this company’s outstanding shares have now reached $25.01 million.
Praxis Precision Medicines Inc (PRAX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Praxis Precision Medicines Inc is 7.44%, while institutional ownership is 89.38%. The most recent insider transaction that took place on Nov 20 ’25, was worth 4,852,256. In this transaction General Counsel and Secretary of this company sold 25,130 shares at a rate of $193.09, taking the stock ownership to the 20,832 shares. Before that another transaction happened on Nov 20 ’25, when Company’s Principal Accounting Officer sold 13,600 for $192.08, making the entire transaction worth $2,612,244. This insider now owns 10,442 shares in total.
Praxis Precision Medicines Inc (PRAX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -2.94 earnings per share (EPS), lower than consensus estimate (set at -2.82) by -0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.65% during the next five years compared to 8.54% growth over the previous five years of trading.
Praxis Precision Medicines Inc (NASDAQ: PRAX) Trading Performance Indicators
Take a look at Praxis Precision Medicines Inc’s (PRAX) current performance indicators. Last quarter, stock had a quick ratio of 5.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1021.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -12.90, a number that is poised to hit -3.09 in the next quarter and is forecasted to reach -12.82 in one year’s time.
Technical Analysis of Praxis Precision Medicines Inc (PRAX)
The latest stats from [Praxis Precision Medicines Inc, PRAX] show that its last 5-days average volume of 0.57 million was inferior to 0.61 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 51.74%.
During the past 100 days, Praxis Precision Medicines Inc’s (PRAX) raw stochastic average was set at 95.32%, which indicates a significant increase from 80.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 13.89 in the past 14 days, which was higher than the 9.61 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $211.47, while its 200-day Moving Average is $86.23. Now, the first resistance to watch is $315.53. This is followed by the second major resistance level at $326.49. The third major resistance level sits at $335.25. If the price goes on to break the first support level at $295.81, it is likely to go to the next support level at $287.05. The third support level lies at $276.09 if the price breaches the second support level.
Praxis Precision Medicines Inc (NASDAQ: PRAX) Key Stats
The company with the Market Capitalisation of 7.62 billion has total of 25,007K Shares Outstanding. Its annual sales at the moment are 8,550 K in contrast with the sum of -182,820 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -73,930 K.
